National Medical Care Co. (Care) reported a net profit after zakat and tax of SAR 60.4 million for the first nine months of 2019, an increase of 5.5 percent year-on-year (YoY), on lower operating costs as part of the company’s cost rationalization strategy.
Meanwhile, a decline in revenue in the same period was partially offset by higher other income.
Item | 9m 2018 | 9m 2019 | Change |
---|---|---|---|
Revenues | 582.11 | 522.88 | (10.2 %) |
Gross Income | 134.49 | 126.38 | (6.0 %) |
Operating Income | 64.97 | 65.50 | 0.8 % |
Net Income | 57.31 | 60.45 | 5.5 % |
Average Shares | 44.85 | 44.85 | - |
EPS (Riyals) | 1.28 | 1.35 | 5.5 % |
The third quarter net profit after zakat and tax jumped 45.4 percent YoY to SAR 16.6 million, thanks to lower operating costs and credit loss provisions, as well as higher gross profit.
When compared to Q2 2019, net profit climbed 20.5 percent, driven by higher revenue as a result of improved patient footfall during the third quarter.
Item | Q3 2018 | Q3 2019 | Change |
---|---|---|---|
Revenues | 176.40 | 173.51 | (1.6 %) |
Gross Income | 33.17 | 40.11 | 20.9 % |
Operating Income | 13.16 | 19.63 | 49.2 % |
Net Income | 11.44 | 16.64 | 45.4 % |
Average Shares | 44.85 | 44.85 | - |
EPS (Riyals) | 0.26 | 0.37 | 45.4 % |
Item | Q2 2019 | Q3 2019 | Change |
---|---|---|---|
Revenues | 169.94 | 173.51 | 2.1 % |
Gross Income | 38.26 | 40.11 | 4.8 % |
Operating Income | 15.56 | 19.63 | 26.2 % |
Net Income | 13.81 | 16.64 | 20.5 % |
Average Shares | 44.85 | 44.85 | - |
EPS (Riyals) | 0.31 | 0.37 | 20.5 % |
Period | Revenues | Change | Gross Income | Change | Net Income | Change | EPS(Riyal) |
---|---|---|---|---|---|---|---|
Q1 2010 | 110.53 | 20.9 % | 29.63 | 48.1 % | 25.67 | 42.1 % | 0.57 |
Q2 2010 | 110.45 | 15.4 % | 26.13 | 31.6 % | 20.70 | 21.5 % | 0.46 |
Q3 2010 | 95.98 | 5.0 % | 23.35 | 70.2 % | 20.51 | 29.2 % | 0.46 |
Q4 2010 | 109.27 | 13.9 % | 24.73 | 9.4 % | 17.87 | 212.4 % | 0.40 |
2010 | 426.22 | 13.8 % | 103.83 | 36.3 % | 84.75 | 49.4 % | 1.89 |
Q1 2011 | 114.09 | 3.2 % | 34.44 | 16.2 % | 28.58 | 11.3 % | 0.64 |
Q2 2011 | 119.28 | 8.0 % | 34.44 | 31.8 % | 28.64 | 38.4 % | 0.64 |
Q3 2011 | 106.50 | 11.0 % | 24.26 | 3.9 % | 18.54 | (9.6 %) | 0.41 |
Q4 2011 | 118.41 | 8.4 % | 28.19 | 14.0 % | 18.96 | 6.1 % | 0.42 |
2011 | 458.28 | 7.5 % | 121.33 | 16.9 % | 94.72 | 11.8 % | 2.11 |
Q1 2012 | 128.87 | 13.0 % | 35.53 | 3.2 % | 28.88 | 1.0 % | 0.64 |
Q2 2012 | 137.27 | 15.1 % | 37.60 | 9.2 % | 29.59 | 3.3 % | 0.66 |
Q3 2012 | 121.00 | 13.6 % | 30.07 | 23.9 % | 21.46 | 15.7 % | 0.48 |
Q4 2012 | 137.61 | 16.2 % | 31.93 | 13.3 % | 25.03 | 32.0 % | 0.56 |
2012 | 524.75 | 14.5 % | 135.13 | 11.4 % | 104.96 | 10.8 % | 2.34 |
Q1 2013 | 145.36 | 12.8 % | 38.75 | 9.0 % | 31.12 | 7.8 % | 0.69 |
Q2 2013 | 142.20 | 3.6 % | 31.78 | (15.5 %) | 22.19 | (25.0 %) | 0.49 |
Q3 2013 | 134.56 | 11.2 % | 24.08 | (19.9 %) | 18.80 | (12.4 %) | 0.42 |
Q4 2013 | 164.16 | 19.3 % | 33.54 | 5.0 % | 20.39 | (18.6 %) | 0.45 |
2013 | 586.28 | 11.7 % | 130.06 | (3.8 %) | 92.50 | (11.9 %) | 2.06 |
Q1 2014 | 181.82 | 25.1 % | 42.99 | 10.9 % | 32.40 | 4.1 % | 0.72 |
Q2 2014 | 179.74 | 26.4 % | 56.27 | 77.0 % | 31.06 | 40.0 % | 0.69 |
Q3 2014 | 177.44 | 31.9 % | 40.16 | 66.8 % | 20.76 | 10.4 % | 0.46 |
Q4 2014 | 194.99 | 18.8 % | 37.85 | 12.9 % | 10.28 | (49.6 %) | 0.23 |
2014 | 733.99 | 25.2 % | 177.27 | 36.3 % | 95.46 | 3.2 % | 2.13 |
Q1 2015 | 219.43 | 20.7 % | 54.12 | 25.9 % | 27.72 | (14.4 %) | 0.62 |
Q2 2015 | 227.86 | 26.8 % | 64.96 | 15.4 % | 42.29 | 36.1 % | 0.94 |
Q3 2015 | 210.78 | 18.8 % | 50.78 | 26.5 % | 25.47 | 22.7 % | 0.57 |
Q4 2015 | 220.60 | 13.1 % | 50.34 | 33.0 % | 35.24 | 242.7 % | 0.79 |
2015 | 878.67 | 19.7 % | 220.20 | 24.2 % | 130.72 | 36.9 % | 2.91 |
Q1 2016 | 253.94 | 15.7 % | 67.29 | 24.3 % | 33.12 | 19.5 % | 0.74 |
Q2 2016 | 259.77 | 14.0 % | 84.30 | 29.8 % | 59.29 | 40.2 % | 1.32 |
Q3 2016 | 197.01 | (6.5 %) | 50.54 | (0.5 %) | 27.55 | 8.2 % | 0.61 |
Q4 2016 | 189.94 | (13.9 %) | 4.86 | (90.3 %) | (69.69) | (297.8 %) | (1.55) |
2016 | 900.65 | 2.5 % | 206.99 | (6.0 %) | 50.27 | (61.5 %) | 1.12 |
Q1 2017 | 202.44 | (20.3 %) | 41.19 | (38.8 %) | 15.54 | (53.1 %) | 0.35 |
Q2 2017 | 216.54 | (16.6 %) | 50.25 | (40.4 %) | 19.50 | (67.1 %) | 0.43 |
Q3 2017 | 208.34 | 5.8 % | 46.97 | (7.1 %) | 27.00 | (2.0 %) | 0.60 |
Q4 2017 | 227.76 | 19.9 % | 57.00 | 1072.0 % | 23.26 | 133.4 % | 0.52 |
2017 | 855.08 | (5.1 %) | 195.40 | (5.6 %) | 85.30 | 69.7 % | 1.90 |
Q1 2018 | 206.67 | 2.1 % | 51.73 | 25.6 % | 25.60 | 64.8 % | 0.57 |
Q2 2018 | 199.05 | (8.1 %) | 49.59 | (1.3 %) | 20.26 | 3.9 % | 0.45 |
Q3 2018 | 176.40 | (15.3 %) | 33.17 | (29.4 %) | 11.44 | (57.6 %) | 0.26 |
Q4 2018 | 181.69 | (20.2 %) | 32.02 | (43.8 %) | 4.87 | (79.1 %) | 0.11 |
2018 | 763.80 | (10.7 %) | 166.51 | (14.8 %) | 62.18 | (27.1 %) | 1.39 |
Q1 2019 | 179.43 | (13.2 %) | 48.01 | (7.2 %) | 29.99 | 17.1 % | 0.67 |
Q2 2019 | 169.94 | (14.6 %) | 38.26 | (22.8 %) | 13.81 | (31.8 %) | 0.31 |
Q3 2019 | 173.51 | (1.6 %) | 40.11 | 20.9 % | 16.64 | 45.4 % | 0.37 |
Period | Revenues | Change | Gross Income | Change | Net Income | Change | EPS(Riyal) |
---|---|---|---|---|---|---|---|
2009 | 374.46 | - | 76.19 | - | 56.71 | - | 1.26 |
2010 | 426.22 | 13.8 % | 103.83 | 36.3 % | 84.75 | 49.4 % | 1.89 |
2011 | 458.28 | 7.5 % | 121.33 | 16.9 % | 94.72 | 11.8 % | 2.11 |
2012 | 524.75 | 14.5 % | 135.13 | 11.4 % | 104.96 | 10.8 % | 2.34 |
2013 | 586.28 | 11.7 % | 130.06 | (3.8 %) | 92.50 | (11.9 %) | 2.06 |
2014 | 733.99 | 25.2 % | 177.27 | 36.3 % | 95.46 | 3.2 % | 2.13 |
2015 | 878.67 | 19.7 % | 220.20 | 24.2 % | 130.72 | 36.9 % | 2.91 |
2016 | 900.65 | 2.5 % | 206.99 | (6.0 %) | 50.27 | (61.5 %) | 1.12 |
2017 | 855.08 | (5.1 %) | 195.40 | (5.6 %) | 85.30 | 69.7 % | 1.90 |
2018 | 763.80 | (10.7 %) | 166.51 | (14.8 %) | 62.18 | (27.1 %) | 1.39 |
Period | Gross Margin | OIBDA Margin | Net Margin Before Unusual Items |
---|---|---|---|
Q1 2010 | 21.80 % | 22.04 % | 16.34 % |
Q2 2010 | 22.55 % | 22.04 % | 16.65 % |
Q3 2010 | 24.63 % | 23.32 % | 17.58 % |
Q4 2010 | 24.36 % | 25.12 % | 19.88 % |
2010 | 24.36 % | 25.12 % | 19.88 % |
Q1 2011 | 25.28 % | 25.61 % | 20.40 % |
Q2 2011 | 26.67 % | 26.85 % | 21.80 % |
Q3 2011 | 26.24 % | 26.11 % | 20.85 % |
Q4 2011 | 26.48 % | 26.55 % | 20.67 % |
2011 | 26.48 % | 26.56 % | 20.67 % |
Q1 2012 | 25.88 % | 25.84 % | 20.09 % |
Q2 2012 | 25.57 % | 25.38 % | 19.54 % |
Q3 2012 | 25.99 % | 25.46 % | 19.56 % |
Q4 2012 | 25.75 % | 25.14 % | 20.00 % |
2012 | 25.75 % | 25.14 % | 20.00 % |
Q1 2013 | 25.56 % | 24.89 % | 19.81 % |
Q2 2013 | 24.27 % | 23.17 % | 18.27 % |
Q3 2013 | 22.61 % | 21.99 % | 17.36 % |
Q4 2013 | 21.86 % | 20.98 % | 15.78 % |
2013 | 22.18 % | 20.98 % | 15.78 % |
Q1 2014 | 21.26 % | 20.31 % | 15.06 % |
Q2 2014 | 23.76 % | 21.17 % | 15.55 % |
Q3 2014 | 24.60 % | 20.97 % | 14.88 % |
Q4 2014 | 24.15 % | 19.46 % | 12.88 % |
2014 | 24.15 % | 19.59 % | 13.01 % |
Q1 2015 | 24.42 % | 18.66 % | 11.64 % |
Q2 2015 | 24.04 % | 18.90 % | 12.33 % |
Q3 2015 | 24.35 % | 19.23 % | 12.40 % |
Q4 2015 | 25.06 % | 21.32 % | 14.88 % |
2015 | 25.06 % | 21.32 % | 14.88 % |
Q1 2016 | 25.56 % | 21.44 % | 14.91 % |
Q2 2016 | 26.74 % | 23.27 % | 16.20 % |
Q3 2016 | 27.11 % | 23.91 % | 16.67 % |
Q4 2016 | 22.98 % | 16.07 % | 9.33 % |
2016 | 22.98 % | 17.75 % | 9.33 % |
Q1 2017 | 21.30 % | 14.58 % | 7.82 % |
Q2 2017 | 18.22 % | 10.27 % | 3.31 % |
Q3 2017 | 17.53 % | 9.96 % | 3.19 % |
Q4 2017 | 22.85 % | 18.52 % | 10.12 % |
2017 | 22.85 % | 18.52 % | 10.12 % |
Q1 2018 | 23.97 % | 20.17 % | 11.24 % |
Q2 2018 | 24.39 % | 20.91 % | 11.57 % |
Q3 2018 | 23.64 % | 20.41 % | 10.10 % |
Q4 2018 | 21.80 % | 20.00 % | 8.14 % |
2018 | 21.80 % | 20.00 % | 8.14 % |
Q1 2019 | 22.10 % | 21.08 % | 9.04 % |
Q2 2019 | 21.41 % | 21.09 % | 8.50 % |
Q3 2019 | 22.48 % | 21.77 % | 9.27 % |
Period | Gross Margin | OIBDA Margin | Net Margin Before Unusual Items |
---|---|---|---|
2009 | 20.35 % | 20.91 % | 15.14 % |
2010 | 24.36 % | 25.12 % | 19.88 % |
2011 | 26.48 % | 26.56 % | 20.67 % |
2012 | 25.75 % | 25.14 % | 20.00 % |
2013 | 22.18 % | 20.98 % | 15.78 % |
2014 | 24.15 % | 19.59 % | 13.01 % |
2015 | 25.06 % | 21.32 % | 14.88 % |
2016 | 22.98 % | 17.75 % | 9.33 % |
2017 | 22.85 % | 18.52 % | 10.12 % |
2018 | 21.80 % | 20.00 % | 8.14 % |
Period | Gross Margin | OIBDA Margin | Net Margin Before Unusual Items |
---|---|---|---|
Q1 2010 | 26.81 % | 28.92 % | 23.22 % |
Q2 2010 | 23.66 % | 24.55 % | 18.74 % |
Q3 2010 | 24.33 % | 25.97 % | 21.37 % |
Q4 2010 | 22.63 % | 21.09 % | 16.35 % |
Q1 2011 | 30.19 % | 30.66 % | 25.05 % |
Q2 2011 | 28.87 % | 29.19 % | 24.01 % |
Q3 2011 | 22.78 % | 22.91 % | 17.41 % |
Q4 2011 | 23.81 % | 23.21 % | 16.01 % |
Q1 2012 | 27.57 % | 27.57 % | 22.41 % |
Q2 2012 | 27.39 % | 27.12 % | 21.56 % |
Q3 2012 | 24.85 % | 23.55 % | 17.74 % |
Q4 2012 | 23.20 % | 22.29 % | 18.19 % |
Q1 2013 | 26.65 % | 26.37 % | 21.41 % |
Q2 2013 | 22.35 % | 20.42 % | 15.60 % |
Q3 2013 | 17.89 % | 18.61 % | 13.97 % |
Q4 2013 | 20.43 % | 18.63 % | 12.42 % |
Q1 2014 | 23.64 % | 22.99 % | 17.82 % |
Q2 2014 | 31.31 % | 23.55 % | 17.28 % |
Q3 2014 | 22.63 % | 18.45 % | 11.70 % |
Q4 2014 | 19.41 % | 13.33 % | 5.27 % |
Q1 2015 | 24.67 % | 19.55 % | 12.63 % |
Q2 2015 | 28.51 % | 23.38 % | 18.56 % |
Q3 2015 | 24.09 % | 19.85 % | 12.09 % |
Q4 2015 | 22.82 % | 22.37 % | 15.97 % |
Q1 2016 | 26.50 % | 20.19 % | 13.04 % |
Q2 2016 | 32.45 % | 29.83 % | 22.83 % |
Q3 2016 | 25.65 % | 22.64 % | 13.99 % |
Q4 2016 | 2.56 % | (15.05 %) | (18.93 %) |
Q1 2017 | 20.35 % | 15.00 % | 7.68 % |
Q2 2017 | 23.20 % | 16.81 % | 9.01 % |
Q3 2017 | 22.54 % | 20.74 % | 12.96 % |
Q4 2017 | 25.02 % | 21.25 % | 10.76 % |
Q1 2018 | 25.03 % | 21.90 % | 12.39 % |
Q2 2018 | 24.91 % | 19.67 % | 10.18 % |
Q3 2018 | 18.81 % | 18.43 % | 6.49 % |
Q4 2018 | 17.62 % | 19.73 % | 2.68 % |
Q1 2019 | 26.76 % | 26.61 % | 16.71 % |
Q2 2019 | 22.51 % | 19.46 % | 8.13 % |
Q3 2019 | 23.12 % | 21.16 % | 9.59 % |
Period | Shares Outstanding (M) | EPS (Riyal) | Adjusted EPS (Riyal) | Book Value (BV) |
---|---|---|---|---|
Q1 2010 | 44.85 | 1.43 | 1.43 | 9.87 |
Q2 2010 | 44.85 | 1.52 | 1.52 | 9.99 |
Q3 2010 | 44.85 | 1.62 | 1.62 | 10.45 |
Q4 2010 | 44.85 | 1.89 | 1.89 | 10.85 |
Q1 2011 | 44.85 | 1.95 | 1.95 | 10.85 |
Q2 2011 | 44.85 | 2.13 | 2.13 | 11.49 |
Q3 2011 | 44.85 | 2.09 | 2.09 | 11.90 |
Q4 2011 | 44.85 | 2.11 | 2.11 | 12.32 |
Q1 2012 | 44.85 | 2.12 | 2.12 | 12.97 |
Q2 2012 | 44.85 | 2.14 | 2.14 | 12.57 |
Q3 2012 | 44.85 | 2.20 | 2.20 | 13.04 |
Q4 2012 | 44.85 | 2.34 | 2.34 | 13.60 |
Q1 2013 | 44.85 | 2.39 | 2.39 | 18.19 |
Q2 2013 | 44.85 | 2.23 | 2.23 | 17.24 |
Q3 2013 | 44.85 | 2.17 | 2.17 | 17.65 |
Q4 2013 | 44.85 | 2.06 | 2.06 | 18.11 |
Q1 2014 | 44.85 | 2.09 | 2.09 | 17.28 |
Q2 2014 | 44.85 | 2.29 | 2.29 | 17.97 |
Q3 2014 | 44.85 | 2.33 | 2.33 | 18.46 |
Q4 2014 | 44.85 | 2.11 | 2.11 | 18.69 |
Q1 2015 | 44.85 | 2.00 | 2.00 | 19.26 |
Q2 2015 | 44.85 | 2.25 | 2.25 | 18.66 |
Q3 2015 | 44.85 | 2.36 | 2.36 | 19.22 |
Q4 2015 | 44.85 | 2.91 | 2.91 | 20.01 |
Q1 2016 | 44.85 | 3.03 | 3.03 | 20.60 |
Q2 2016 | 44.85 | 3.41 | 3.41 | 21.16 |
Q3 2016 | 44.85 | 3.46 | 3.46 | 21.75 |
Q4 2016 | 44.85 | 1.12 | 1.87 | 20.18 |
Q1 2017 | 44.85 | 0.73 | 1.48 | 20.51 |
Q2 2017 | 44.85 | (0.16) | 0.59 | 20.93 |
Q3 2017 | 44.85 | (0.17) | 0.58 | 21.52 |
Q4 2017 | 44.85 | 1.90 | 1.93 | 21.98 |
Q1 2018 | 44.85 | 2.13 | 2.15 | 22.38 |
Q2 2018 | 44.85 | 2.14 | 2.17 | 21.83 |
Q3 2018 | 44.85 | 1.80 | 1.82 | 22.09 |
Q4 2018 | 44.85 | 1.39 | 1.39 | 22.23 |
Q1 2019 | 44.85 | 1.48 | 1.48 | 22.90 |
Q2 2019 | 44.85 | 1.34 | 1.34 | 22.20 |
Q3 2019 | 44.85 | 1.46 | 1.46 | 22.57 |
Period | Shares Outstanding (M) | EPS (Riyal) | Adjusted EPS (Riyal) | Book Value (BV) |
---|---|---|---|---|
2009 | 44.85 | 1.26 | 1.26 | 9.29 |
2010 | 44.85 | 1.89 | 1.89 | 10.85 |
2011 | 44.85 | 2.11 | 2.11 | 12.32 |
2012 | 44.85 | 2.34 | 2.34 | 13.60 |
2013 | 44.85 | 2.06 | 2.06 | 18.11 |
2014 | 44.85 | 2.13 | 2.13 | 18.69 |
2015 | 44.85 | 2.91 | 2.91 | 20.01 |
2016 | 44.85 | 1.12 | 1.87 | 20.18 |
2017 | 44.85 | 1.90 | 1.93 | 21.98 |
2018 | 44.85 | 1.39 | 1.39 | 22.23 |
Period | P/E | Adjusted P/E | Price/book |
---|---|---|---|
Q1 2010 | - | - | - |
Q2 2010 | - | - | - |
Q3 2010 | - | - | - |
Q4 2010 | - | - | - |
Q1 2011 | - | - | - |
Q2 2011 | - | - | - |
Q3 2011 | - | - | - |
Q4 2011 | - | - | - |
Q1 2012 | - | - | - |
Q2 2012 | - | - | - |
Q3 2012 | - | - | - |
Q4 2012 | - | - | - |
Q1 2013 | 30.02 | 30.02 | 3.94 |
Q2 2013 | 26.07 | 26.07 | 3.37 |
Q3 2013 | 25.16 | 25.16 | 3.09 |
Q4 2013 | 26.43 | 26.43 | 3.01 |
Q1 2014 | 29.41 | 29.41 | 3.56 |
Q2 2014 | 32.48 | 32.48 | 4.14 |
Q3 2014 | 32.55 | 32.55 | 4.11 |
Q4 2014 | 26.03 | 26.03 | 2.94 |
Q1 2015 | 30.88 | 30.88 | 3.21 |
Q2 2015 | 28.44 | 28.44 | 3.44 |
Q3 2015 | 22.37 | 22.37 | 2.74 |
Q4 2015 | 19.04 | 19.04 | 2.77 |
Q1 2016 | 16.69 | 16.69 | 2.46 |
Q2 2016 | 18.71 | 18.71 | 3.02 |
Q3 2016 | 15.98 | 15.98 | 2.54 |
Q4 2016 | 58.81 | 35.19 | 3.27 |
Q1 2017 | 73.26 | 36.05 | 2.60 |
Q2 2017 | NEG | 79.11 | 2.25 |
Q3 2017 | NEG | 69.35 | 1.87 |
Q4 2017 | 22.90 | 22.57 | 1.98 |
Q1 2018 | 26.45 | 26.11 | 2.51 |
Q2 2018 | 27.67 | 27.32 | 2.72 |
Q3 2018 | 25.44 | 25.05 | 2.07 |
Q4 2018 | 36.28 | 36.28 | 2.26 |
Q1 2019 | 31.56 | 31.56 | 2.05 |
Q2 2019 | 43.34 | 43.34 | 2.62 |
Q3 2019 | 37.22 | 37.22 | 2.40 |
Period | P/E | Adjusted P/E | Price/book |
---|---|---|---|
2009 | - | - | - |
2010 | - | - | - |
2011 | - | - | - |
2012 | - | - | - |
2013 | 26.43 | 26.43 | 3.01 |
2014 | 25.77 | 25.77 | 2.94 |
2015 | 19.04 | 19.04 | 2.77 |
2016 | 58.81 | 35.19 | 3.27 |
2017 | 22.90 | 22.57 | 1.98 |
2018 | 36.28 | 36.28 | 2.26 |
Q3 2019
2019
Period | Medical Services | Pharmacies |
---|---|---|
Q1 2010 | 85.68 | 24.84 |
Q2 2010 | 84.16 | 26.29 |
Q3 2010 | 74.56 | 21.42 |
Q4 2010 | 84.07 | 25.20 |
Q1 2011 | 89.20 | 24.89 |
Q2 2011 | 94.51 | 24.77 |
Q3 2011 | 84.02 | 22.49 |
Q4 2011 | 93.61 | 24.79 |
Q1 2012 | 102.83 | 26.04 |
Q2 2012 | 109.44 | 27.83 |
Q3 2012 | 96.87 | 24.14 |
Q4 2012 | 109.84 | 27.76 |
Q1 2013 | 117.72 | 27.65 |
Q2 2013 | 115.21 | 26.98 |
Q3 2013 | 109.28 | 25.28 |
Q4 2013 | 134.04 | 30.12 |
Q1 2014 | 149.16 | 32.67 |
Q2 2014 | 149.31 | 30.43 |
Q3 2014 | 149.57 | 27.87 |
Q4 2014 | 161.93 | 33.06 |
Q1 2015 | 184.80 | 34.63 |
Q2 2015 | 196.41 | 31.45 |
Q3 2015 | 180.37 | 30.41 |
Q4 2015 | 191.80 | 28.80 |
Q1 2016 | 220.78 | 33.16 |
Q2 2016 | 230.14 | 29.62 |
Q3 2016 | 173.08 | 23.93 |
Q4 2016 | 162.66 | 27.28 |
Q1 2017 | 176.04 | 26.40 |
Q2 2017 | 190.13 | 26.41 |
Q3 2017 | 185.07 | 23.27 |
Q4 2017 | 202.08 | 25.76 |
Q1 2018 | 183.47 | 23.20 |
Q2 2018 | 175.85 | 23.20 |
Q3 2018 | 155.67 | 20.74 |
Q4 2018 | 154.94 | 26.74 |
Q1 2019 | 157.71 | 21.72 |
Q2 2019 | 149.87 | 20.07 |
Q3 2019 | 153.76 | 19.76 |
Period | Medical Services | Pharmacies |
---|---|---|
2010 | 328.47 | 97.75 |
2011 | 361.34 | 96.95 |
2012 | 418.98 | 105.76 |
2013 | 476.25 | 110.02 |
2014 | 609.97 | 124.03 |
2015 | 753.38 | 125.28 |
2016 | 786.66 | 113.99 |
2017 | 753.32 | 101.85 |
2018 | 669.93 | 93.87 |
Item | Q3 2019 (e) | Q3 2019 (a) | Change |
---|---|---|---|
Average | 14.47 | 16.64 | 15.05 % |
Item | Q3 2019 (e) | Q3 2019 (a) | Change |
---|---|---|---|
OSOOL AND BAKHEET | 16.60 | 16.64 | 0.3 % |
AlJazira Capital | 15.80 | 16.64 | 5.3 % |
Al Rajhi Capital | 11.00 | 16.64 | 51.3 % |
Current | |
Market Cap (M Riyal) | 9,014.85 |
Enterprise Value (EV) (M) | 8,711.86 |
Shares Outstanding ((M)) | 44.85 |
EPS ( Riyal) (TTM) | 5.93 |
Book Value (BV) ( Riyal) | 34.22 |
Par Value ( Riyal) | 10.00 |
Adjusted P/E (Last12) | 36.04 |
P/E (TTM) | 33.90 |
Price/book | 5.87 |
Return on Average Assets (%) (TTM) | 13.2 |
Return on Average Equity (%) (TTM) | 18.6 |
Argaam Investment Company has updated the Privacy Policy of its services and digital platforms. Know more about our Privacy Policy here.
Argaam uses cookies to personalize content, to provide social media features and analyze traffic, that we might also share with third parties. You consent to our cookies if you use this website
Comments {{getCommentCount()}}
Be the first to comment
رد{{comment.DisplayName}} على {{getCommenterName(comment.ParentThreadID)}}
{{comment.DisplayName}}
{{comment.ElapsedTime}}